{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:15:12Z","timestamp":1778706912193,"version":"3.51.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Kyowa Kirin, Germany"},{"name":"Clinician Scientist Program TITUS\u2014The First Thousand Days of Life\u2014Fr\u00fche Pr\u00e4gung und Pr\u00e4vention"},{"name":"Else Kr\u00f6ner-Fresenius-Stiftung and Hannover Medical School"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Burosumab is effective for treatment of rickets in children with X-linked hypophosphatemia (XLH). The effects of burosumab on markers and regulators of osteoblast and osteoclast activity are largely unknown. In this cross-sectional observational study, we investigated 7 key markers and regulators of osteoblast and osteoclast activity in 107 burosumab-treated children with XLH. We calculated z-scores for bone-specific alkaline phosphatase (BAP), procollagen-1-N-terminal propeptide (P1NP), carboxy-terminal telopeptide of type 1 collagen (CTX), tartrate-resistant acid phosphatase type 5b (TRAP5b), soluble RANKL (sRANKL), osteoprotegerin (OPG), and sclerostin. The median age at investigation and duration of burosumab treatment were 10.7 and 2.2\u00a0yr, respectively, with 18.7% of patients on primary burosumab treatment and 81.3% with prior treatment with phosphate and active vitamin D. Height and BMI improved by approximately 0.3 z-score from baseline with burosumab treatment, and serum phosphate, 1,25-dihydroxyvitamin D, and alkaline phosphatase improved by 2 z-scores (each p\u2009&amp;lt;\u2009.01 vs prior burosumab), but phosphate (\u22121.8 z-score) and calcium (\u22120.65 z-score) remained reduced (each p\u2009&amp;lt;\u2009.001 vs age and sex-specific reference values). The z-scores for osteoblast (BAP, P1NP) and osteoclast (CTX, TRAP5b) activity markers and for the osteoblast suppressor sclerostin were increased (each p\u2009&amp;lt;\u2009.001). Standardized sRANKL was reduced (p\u2009&amp;lt;\u2009.05), while the RANKL inhibitor OPG was increased resulting in a reduced sRANKL\/OPG ratio (each p\u2009&amp;lt;\u2009.001). Multivariate analysis revealed significant associations between serum sclerostin and serum phosphate (negative), serum calcium and vitamin D sufficiency (positive), and primary burosumab treatment with BAP (negative). In this real-world setting, pediatric XLH patients receiving burosumab treatment showed persisting mild hypophosphatemia and increased markers of osteoblast and osteoclast activity despite negative counter-regulation of osteoblasts by sclerostin and osteoclasts by OPG\/RANKL. Our data suggest a more pronounced normalization osteoblast activity when children are primarily treated with burosumab and underscore the need for adequate vitamin D supplementation.<\/jats:p>","DOI":"10.1093\/jbmr\/zjag071","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:44:17Z","timestamp":1777031057000},"source":"Crossref","is-referenced-by-count":0,"title":["Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumab"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0979-6382","authenticated-orcid":false,"given":"Ineke","family":"B\u00f6ckmann","sequence":"first","affiliation":[{"name":"Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School , 30175 Hannover ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-7622","authenticated-orcid":false,"given":"Maren","family":"Leifheit-Nestler","sequence":"additional","affiliation":[{"name":"Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School , 30175 Hannover ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9534-4102","authenticated-orcid":false,"given":"Mirko","family":"Rehberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne , 50937 Cologne ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Spart\u00e0","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, University Children's Hospital Zurich , 8008 Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Evers","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, University Children's Hospital Zurich , 8008 Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Peter","family":"Schlingmann","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Pediatric Nephrology, University Children\u2019s Hospital , 48149 M\u00fcnster ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J","family":"Kemper","sequence":"additional","affiliation":[{"name":"Asklepios Children\u2019s Hospital Hamburg-Heidberg , 22417 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Richter-Unruh","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital Bochum , 44791 Bochum ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothee","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetes, Department of Pediatric and Adolescent Medicine, University of L\u00fcbeck , 23538 L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7490-4983","authenticated-orcid":false,"given":"Olaf","family":"Hiort","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetes, Department of Pediatric and Adolescent Medicine, University of L\u00fcbeck , 23538 L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Grohmann-Held","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital Greifswald , 17475 Greifswald ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Schr\u00f6der","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital Greifswald , 17475 Greifswald ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Derichs","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital , 55131 Mainz ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Freiberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medicine G\u00f6ttingen , 37075 G\u00f6ttingen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Weitz","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics and Hematology\/Oncology, University Hospital T\u00fcbingen, University Children\u2019s Hospital , 72076 T\u00fcbingen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Dunstheimer","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetes, Department of Pediatric and Adolescent Medicine, University Hospital of Augsburg , 86156 Augsburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Schmid","sequence":"additional","affiliation":[{"name":"Pediatric practice Dres. Schmid, Bettendorf, Hammon & Zimmermann , 96114 Hirschaid ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"John-Kroegel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, University Children\u2019s Hospital , Jena ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Metzing","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, University Children\u2019s Hospital , 07747 Jena ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Heger","sequence":"additional","affiliation":[{"name":"Kinderkrankenhaus auf der Bult, Pediatric Endocrinology , 30173 Hannover ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Jorch","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital, Evangelisches Klinikum Bethel , 33617 Bielefeld ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagen","family":"Staude","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, University Children\u2019s Hospital Rostock , 18057 Rostock ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Patzer","sequence":"additional","affiliation":[{"name":"St. Elisabeth and St. Barbara Children\u2019s Hospital , 06110 Halle\/Saale ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Medical Faculty Heidelberg, Center for Pediatrics and Adolescent Medicine, Heidelberg University , 69120 Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Joachim","family":"Partsch","sequence":"additional","affiliation":[{"name":"MVZ Endokrinologikum Hamburg , 22767 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"H\u00fcbner","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology, University Children\u2019s Hospital, Technical University Dresden , 01307 Dresden ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Marx","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department Pediatrics, University Hospital of Erlangen , 91054 Erlangen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Land","sequence":"additional","affiliation":[{"name":"Center for Pediatric Endocrinology , 82131 Gauting ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Albers","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Christliches Kinderhospital , 49074 Osnabrueck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Banzer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Christliches Kinderhospital , 49074 Osnabrueck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inka","family":"Baus","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Paediatrics, Christian-Albrechts-Universit\u00e4t Kiel , 24105 Kiel ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Wilkening","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, Department of Pediatric, Helios Clinic Schwerin , 19049 Schwerin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Klinikum Links der Weser , 28277 Bremen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Wagner","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetology, Pediatric Practice Rostock , 18057 Rostock ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Krauch","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, University Medicine , 68167 Mannheim ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Gessner","sequence":"additional","affiliation":[{"name":"KfH-Board of Trustees for Dialysis and Kidney Transplantation (KfH-Kuratorium f\u00fcr Dialyse und Nierentransplantation e.V.) , 80804 Munich ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Goischke","sequence":"additional","affiliation":[{"name":"Nephrology Department, University Children\u2019s Hospital , 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-712X","authenticated-orcid":false,"given":"Miroslav","family":"Zivicnjak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School , 30175 Hannover ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Center for Chronically Sick Children, Pediatric Endocrinology, University Medicine-Charit\u00e9 , 13353 Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-7813","authenticated-orcid":false,"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[{"name":"Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School , 30175 Hannover ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the German Society for Pediatric Nephrology (GPN) and the German Society for Pediatric and Adolescent Endocrinology and Diabetology (DGPAED)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"10455","key":"2026051317010090100_ref1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/s0140-6736(24)01305-9","article-title":"X-linked hypophosphataemia","volume":"404","author":"Kamenick\u00fd","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"2026051317010090100_ref2","doi-asserted-by":"publisher","first-page":"e1002427","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic FGF23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PLoS Biol"},{"key":"2026051317010090100_ref3","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/jbmr.4101","article-title":"Genetic ablation of osteopontin in osteomalacic Hyp mice partially rescues the deficient mineralization without correcting hypophosphatemia","volume":"35","author":"Hoac","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026051317010090100_ref4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41581-024-00926-x","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"21","author":"Haffner","year":"2025","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"2026051317010090100_ref5","doi-asserted-by":"publisher","first-page":"ziae118","DOI":"10.1093\/jbmrpl\/ziae118","article-title":"Impact of X-linked hypophosphatemic rickets\/osteomalacia on health and quality of life: baseline data from the SUNFLOWER longitudinal, observational cohort study","volume":"8","author":"Namba","year":"2024","journal-title":"JBMR Plus"},{"issue":"2","key":"2026051317010090100_ref6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00223-022-00964-2","article-title":"Bone turnover markers in children: from laboratory challenges to clinical interpretation","volume":"112","author":"Ladang","year":"2023","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2026051317010090100_ref7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"issue":"10","key":"2026051317010090100_ref8","doi-asserted-by":"publisher","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One"},{"key":"2026051317010090100_ref9","doi-asserted-by":"publisher","first-page":"117319","DOI":"10.1016\/j.bone.2024.117319","article-title":"Osteoprotegerin secretion and its inhibition by RANKL in osteoblastic cells visualized using bioluminescence imaging","volume":"191","author":"Ninomiya","year":"2025","journal-title":"Bone."},{"issue":"1","key":"2026051317010090100_ref10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00223-021-00823-6","article-title":"Sclerostin directly stimulates osteocyte synthesis of fibroblast growth factor-23","volume":"109","author":"Ito","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2026051317010090100_ref11","doi-asserted-by":"publisher","first-page":"E920","DOI":"10.1210\/jc.2013-3852","article-title":"Circulating sclerostin in children and young adults with heritable bone disorders","volume":"99","author":"Palomo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026051317010090100_ref12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00223-019-00526-z","article-title":"Elevated bone remodeling markers of CTX and P1NP in addition to sclerostin in patients with X-linked hypophosphatemia: a cross-sectional controlled study","volume":"104","author":"Hansen","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"2026051317010090100_ref13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae782","article-title":"Bone microarchitecture evaluated by HR-pQCT in Chinese adolescent and pediatric patients with X-linked hypophosphatemia","volume":"110","author":"Wu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10189","key":"2026051317010090100_ref14","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/s0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"2026051317010090100_ref15","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm. International trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026051317010090100_ref16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1210\/clinem\/dgab729","article-title":"Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia","volume":"107","author":"Linglart","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026051317010090100_ref17","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1210\/clinem\/dgad223","article-title":"Effects of burosumab treatment on mineral metabolism in children and adolescents with X-linked hypophosphatemia","volume":"108","author":"Ewert","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026051317010090100_ref18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/archdischild-2022-324962","article-title":"Burosumab in management of X-linked hypophosphataemia: a retrospective cohort study of growth and serum phosphate levels","volume":"108","author":"Walker","year":"2023","journal-title":"Arch Dis Child"},{"key":"2026051317010090100_ref19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf093","article-title":"X-linked hypophosphatemia management in children: an International Working Group Clinical Practice Guideline","volume":"110","author":"Ali","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051317010090100_ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf079","article-title":"Switching from active vitamin d and phosphate supplementation to burosumab significantly corrects lower limb malalignment in pediatric X-linked hypophosphatemia","author":"Ward","year":"2025;40(12):1332-1342","journal-title":"J Bone Miner Res"},{"key":"2026051317010090100_ref21","doi-asserted-by":"publisher","first-page":"117044","DOI":"10.1016\/j.bone.2024.117044","article-title":"Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: analysis of human iPS cell models generated by CRISPR\/Cas9-mediated gene ablation","volume":"181","author":"Nakanishi","year":"2024","journal-title":"Bone"},{"key":"2026051317010090100_ref22","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00198-014-2808-0","article-title":"Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?","volume":"25","author":"Sapir-Koren","year":"2014","journal-title":"Osteoporos Int"},{"issue":"7","key":"2026051317010090100_ref23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2026051317010090100_ref24","volume-title":"Crysvita Annex I - Summary of Product Characteristics, Authorization Number EU\/1\/17\/1262\/001","year":"2018"},{"key":"2026051317010090100_ref25","volume-title":"Crysvita Annex I - Summary of Product Characteristics, Authorization Number EU\/1\/17\/1262\/001","year":"2022"},{"issue":"3","key":"2026051317010090100_ref26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1210\/clinem\/dgad597","article-title":"LMS-based pediatric reference values for parameters of phosphate homeostasis in the HARP cohort","volume":"109","author":"Pott","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051317010090100_ref27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.clinbiochem.2019.08.010","article-title":"Continuous reference intervals for 38 biochemical markers in healthy children and adolescents: comparisons to traditionally partitioned reference intervals","volume":"73(1)","author":"Asgari","year":"2019","journal-title":"Clin Biochem"},{"issue":"2","key":"2026051317010090100_ref28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1210\/jc.2015-2175","article-title":"Global Consensus Recommendations on Prevention and Management of Nutritional Rickets","volume":"101","author":"Munns","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026051317010090100_ref29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1210\/jcem-67-2-353","article-title":"Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay","volume":"67","author":"Blind","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026051317010090100_ref30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/10408363.2017.1379945","article-title":"The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper","volume":"54","author":"Adeli","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"6","key":"2026051317010090100_ref31","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1515\/cclm-2017-0767","article-title":"Pediatric reference intervals for 1,25-dihydroxyvitamin D using the DiaSorin LIAISON XL assay in the healthy CALIPER cohort","volume":"56","author":"Higgins","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"Pt 6","key":"2026051317010090100_ref32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1258\/acb.2012.011274","article-title":"Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase","volume":"49","author":"Fischer","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"2026051317010090100_ref33","doi-asserted-by":"publisher","first-page":"115124","DOI":"10.1016\/j.bone.2019.115124","article-title":"Children and adolescents with obesity have reduced serum bone turnover markers and 25-hydroxyvitamin D but increased parathyroid hormone concentrations - results derived from new pediatric reference ranges","volume":"132","author":"Geserick","year":"2020","journal-title":"Bone"},{"issue":"3","key":"2026051317010090100_ref34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00198-023-06959-5","article-title":"LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort","volume":"35","author":"Tietze","year":"2024","journal-title":"Osteoporos Int"},{"issue":"2","key":"2026051317010090100_ref35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00467-010-1705-9","article-title":"Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets","volume":"26","author":"Zivi\u010dnjak","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"21","key":"2026051317010090100_ref36","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"2026051317010090100_ref37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s2213-8587(18)30338-3","article-title":"Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026051317010090100_ref38","doi-asserted-by":"publisher","first-page":"1496386","DOI":"10.3389\/fendo.2024.1496386","article-title":"Case report: prolonged and severe hungry bone syndrome after parathyroidectomy in X-linked hypophosphatemia","volume":"15","author":"Puliani","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2026051317010090100_ref39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","article-title":"The role of phosphatases in the initiation of skeletal mineralization","volume":"93","author":"Mill\u00e1n","year":"2013","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2026051317010090100_ref40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11914-014-0223-2","article-title":"Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis","volume":"12","author":"White","year":"2014","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2026051317010090100_ref41","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.1.05989","article-title":"Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets","volume":"183","author":"Bresler","year":"2004","journal-title":"J Endocrinol"},{"key":"2026051317010090100_ref42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/B978-0-12-801238-3.65194-2","volume-title":"Encyclopedia of Endocrine Diseases","author":"Cavalier","year":"2018","edition":"2nd"},{"issue":"2","key":"2026051317010090100_ref43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"2026051317010090100_ref44","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1210\/clinem\/dgab579","article-title":"Low levels of serum sclerostin in adult patients with tumor-induced osteomalacia compared with X-linked hypophosphatemia","volume":"107","author":"Ni","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026051317010090100_ref45","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jbmr.3923","article-title":"Sclerostin antibody treatment increases bone mass and normalizes circulating phosphate levels in growing Hyp mice","volume":"35","author":"Carpenter","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2026051317010090100_ref46","doi-asserted-by":"publisher","first-page":"e3241","DOI":"10.1210\/clinem\/dgac296","article-title":"Effect of burosumab compared with conventional therapy on younger vs older children with X-linked hypophosphatemia","volume":"107","author":"Ward","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026051317010090100_ref47","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026051317010090100_ref48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00223-018-0491-4","article-title":"Association of serum sclerostin with bone sclerostin in chronic kidney disease is lost in glucocorticoid treated patients","volume":"104","author":"Boltenst\u00e5l","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"2026051317010090100_ref49","doi-asserted-by":"publisher","first-page":"ziag008","DOI":"10.1093\/jbmrpl\/ziag008","article-title":"Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment","volume":"10","author":"Portale","year":"2026","journal-title":"JBMR Plus"},{"issue":"1","key":"2026051317010090100_ref50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jcph.1950","article-title":"Population pharmacokinetics and pharmacodynamics of burosumab in adult and Pediatric patients with X-linked hypophosphatemia","volume":"62","author":"Lee","year":"2022","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag071\/68159134\/zjag071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag071\/68159134\/zjag071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:01:07Z","timestamp":1778706067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article\/doi\/10.1093\/jbmr\/zjag071\/8662425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag071","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"article-number":"zjag071"}}